ArticleJournal of experimental & clinical cancer research : CR2022

Inhibition of HSP 90 is associated with potent anti-tumor activity in Papillary Renal Cell Carcinoma.

Roma Pahwa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.